Novartis To Collect Contract Pharmacy Claims Data Through 340B ESP, TPAs and Specialty Pharmacies Express Concern Over Data Submitted

Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020, covered entities will be required…